 BERKELEY HEIGHTS, N.J. , May 03, 2022 GLOBE NEWSWIRE -- CorMedix Inc. Nasdaq: CRMD, a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that it will report its financial results for the first quarter ended March 31, 2022, after the market close on Thursday, May 12, 2022, and will host a corporate update conference call at 4:30pm Eastern Time. 